Atlas Trials

Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients

Clinical trial NCT06079827 · UNKNOWN

Trial details

NCT number
NCT06079827
Sponsor
MaxWell Clinic, PLC
Status
UNKNOWN
Study type
OBSERVATIONAL
Alzheimer Disease
Start date
2022-03-22
Primary completion
2024-09-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.